Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Ingevity Corp Stock

Price
Target price
?

?

0.690%
0.4
0.690%
€58.30
 
08:46 / Stuttgart Stock Exchange WKN: A2AHZS / Symbol: NGVT / Name: Ingevity / Stock / Chemicals / Mid Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Ingevity Corp in the next few years
Wizard

Ingevity Corp Stock

Ingevity Corp gained 0.690% compared to yesterday.
Ingevity Corp is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
However, we have a potential of -0.09% for Ingevity Corp as the target price of 58 € is below the current price of 58.05 €.
What does Ingevity do?

Pros and Cons of Ingevity Corp in the next few years

Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Ingevity Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Ingevity Corp 0.690% 0.814% -12.959% 41.569% 11.589% - -
PTT Global Chemical -fgn- -3.090% 6.522% 5.000% 50.615% 37.383% -38.750% -58.475%
Braskem Pfd ADR 0.980% -2.041% 26.316% 9.714% 58.678% -38.560% -65.091%
Barito Pacific Tbk PT -7.030% -26.012% -45.763% 93.939% -58.974% 91.045% 43.820%

Comments

Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for NGVT provided by MarketBeat
Show more

StockNews.com 
0
Report Share
01.03.26 Buy -3.49%

Ingevity (NGVT) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for NGVT provided by MarketBeat
Show more

Jefferies Financial Group Inc. 
0
Report Share
26.02.26 Buy -1.36%
Prediction Buy
Perf. (%) 26.24%
Target price 60.102
Change
Ends at 10.12.26

Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat
Show more

BMO Capital Markets 
0
Report Share
10.12.25
Show more
Not a member yet? Sign up for free!

News

Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points: https://cdn.content.foolcdn.com/images/1umn9qeh/production/c1631655103f7157a9e8d36ebaec7d6a2cfb7675-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points

On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million.

In a U.S. Securities and Exchange Commission (SEC) filing dated

TheMotleyFool 
0 15:00